Clinical Trials Directory

Trials / Unknown

UnknownNCT05802641

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer

Clinical Study of Stereotactic Radiotherapy With Different Fractionation Modes for Early Lung Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The goal of this observational study is to study the efficacy and safety of stereotactic body radiotherapy (SBRT) with different fractionation modes for early lung cancer. The main questions it aims to answer are: How effective are different regimens of SBRT for early lung cancer? How safe are different regimens of SBRT of SBRT for early lung cancer?

Detailed description

The goal of this observational study is to study the efficacy and safety of stereotactic body radiotherapy (SBRT) with different fractionation modes for early lung cancer.. This study intends to review the patients with early lung cancer receiving SBRT of 30Gy/1f or 36Gy/3f from 2018 to 2024 in our center.

Conditions

Interventions

TypeNameDescription
RADIATIONSBRTParticipants with early lung cancer receive single fraction (30Gy/1f) or multiple fractions of SBRT(36Gy/3f).

Timeline

Start date
2018-01-07
Primary completion
2024-01-01
Completion
2025-01-01
First posted
2023-04-06
Last updated
2023-04-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05802641. Inclusion in this directory is not an endorsement.

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer (NCT05802641) · Clinical Trials Directory